Hamburg, Germany (September 14, 2016) Clariness, a global provider of patient engagement, feasibility, clinical trial patient recruitment and retention, announces The Patient’s Voice, a free seminar that will take place on Thursday, October 13, 2016 at the Bridgewater Marriott Hotel in Bridgewater, NJ.
This event agenda will feature research findings, insights and recommendations from sponsors who are currently developing patient-friendly drug development programs, research sites who conduct clinical trials on a daily basis, and patients themselves.
Discussion topics will focus on current developments in patient-centric clinical research, health literacy, and expanding clinical trial access to broader patient populations.
“There are boundless opportunities to learn from patients in every phase of drug development and throughout the product lifecycle,” said Michael Stadler, CEO and co-founder of Clariness. “Patient voices are essential to development of feasible protocols, better communication materials and research models that elevate patients to the center. We invite our industry colleagues to attend this event and learn from patients across a wide range of diseases and conditions.”
Patient panel groups representing chronic, rare and oncological diseases will discuss clinical trial decision influences and barriers to participation. Panel topics also include health information sources, communication preferences and research design.
This free event for research sites, contract research organizations and sponsors requires advance registration. About Clariness
With a dual focus on patients and sites that begins early in clinical development, Clariness finds, engages and recruits targeted patient populations who meet the stringent eligibility criteria of today’s complex clinical trials. Using rich data sources paired with tools for simulation and prediction, we help sponsors identify the best sites, and support them through the enrollment process to reduce burden, avoid delays and boost clinical trial patient recruitment. For more information, visit https://www.clariness.com/
